Estimation of the level of serum IL-40 and IL-41 in Chronic Myeloid Leukemia of Iraqi Patients
DOI:
https://doi.org/10.48047/jsy4c352Keywords:
Cytokines, Chronic myeloid leukemia, IL-40; IL-41, Immune response.Abstract
Background: Chronic Myeloid Leukemia (CML) is a type of cancer that affects the blood and bone marrow. It is characterized by the overproduction of myeloid cells and is often associated with a specific genetic mutation known as the Philadelphia chromosome.
Objective: Determine the levels of IL-40 and IL-41 in the serum of Iraqi patients with CML disease and their function in determining disease severity.
Downloads
References
- CHEREDA, B. & MELO, J. V. 2015. Natural course and biology of CML. Annals of Hematology, 94, 107-121.
- OSMAN, A. E. G. & DEININGER, M. W. 2021. Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions. Blood Rev, 49, 100825.
- VARDIMAN, J. W. 2009. Chronic Myelogenous Leukemia, BCR-ABL1+. American Journal of Clinical Pathology, 132, 250-260.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
